Potential COVID-19 drug azithromycin may increase risk for cardiac events

hi INDiA

Washington [US], September 17 (ANI): Azithromycin — a commonly-prescribed antibiotic — is being investigated as a potential treatment for COVID-19.Azithromycin’s association with cardiac events also has been debated. In 2012, the FDA issued a warning for azithromycin stating that it had been linked to cardiac events, but subsequent studies have yielded mixed results.Now, researchers from […]

The post Potential COVID-19 drug azithromycin may increase risk for cardiac events appeared first on hi INDiA.
http://dlvr.it/RgnfQZ